Michael Wong

Why purpose-driven firms are now more important than ever.

In this installment of the Harvard Business School Healthcare Alumni Association (HBSHAA) Q&A series, Michael Wong talks to Robert E. Siegel, lecturer in management at the Stanford Graduate School of Business, about determining the optimal combination of digital and physical assets for an S&P 500’s growth playbook.

Joseph A. DiAngelo, EdD, dean of the Erivan K. Haub School of Business at Saint Joseph’s University (SJU), discusses how the school’s programs reinforce real-world lessons and prepare younger generations to deal with a career environment in flux.

Ariel Katz, CEO and co-founder of H1, talks about how to find the right KOL for the right audience at the right time.

As emerging technologies are identified, C-suites need to determine how they might be pragmatically deployed as solutions to address their pain points, says IBM‘s Dr. Bernard S. Meyerson.

Alicia H. Munnell, Peter F. Drucker Professor of Management Sciences at Boston College’s Carroll School of Management, talks about building long-term financial health via career sustainability.

The MIT Institute for Work and Employment Research’s Dr. Thomas Kochan offers three key insights on engaging with AI and other digital solutions as they continue to transform the working environment.

Chris Doerr, Senior Vice President, Global Generic Sourcing, AmerisourceBergen, talks about the importance of companies taking an honest view of their current-state capabilities when embarking on the digital transformation journey.

Carolynn Johnson talks about changing the diversity, equity and includsion trends among the most progressive companies.

Landmark Bio CEO Ran Zheng talks about the value of collaborating with best-in-class partners.

Chairman of the Harvard China Fund, Dr. William C. Kirby, talks about the potential impact on multinational western pharma firms of disruption in China.

Dr. Randall N. Hyer, SVP Global Medical Affairs at Moderna, talks about the strategies that have helped the company grow from startup to multi-billion-dollar firm in a decade.

Insights from AmerisourceBergen EVP and Chief Strategy Officer, Leslie Donato.

Harvard Business School Professor Joseph B. Fuller talks about the future prospects for pharma sales forces as they face more restrictions on accessing their target physicians and looming concerns of automation.

Amgen board member and serial CEO Fred Hassan talks about the three levers Fortune 500 C-suites should consider as they position their firms from pilots to enterprise-wide digital transformation.

Dr. Andrew (Drew) Otoo talks about how pharma employees can elevate their own value propositions.

Dr. Amy P. Abernethy talks about her career moves from academia to industry to the US Food & Drug Administation.

Rajit Kamal, Vice President, Asia Pacific for DePuy Synthes, a Johnson & Johnson company, offers recommendations for those wishing to secure an expatriate assignment with their company.

Mark Altmeyer, CEO of Arvelle, offers three recommendations for big pharma executives who are considering making the leap to startups.

Todd Nichols, chief commercial officer of Alkermes, gives his top three recommendations for going all-in to digitally transform the frontline sales team.

Michael Wong speaks to Frank Cespedes, a senior lecturer at Harvard Business School, about how biopharma companies should be optimizing their sales and engagement activities for the 2020s.

In this installment of the Harvard Business School Healthcare Alumni Association (HBSHAA) Q&A series, Percival Barretto-Ko, President of Astellas Pharma, US, speaks to Michael Wong about why value and innovation are the top two focus areas to add to resumes in 2020.

Dr. George Westerman talks to Michael Wong about how smarter executives will successfully lead their workforces in a post COVID-19 business environment.

Dr. Geeta Vemuri, founder of biopharma investment firm Agent Capital, talks about sustaining a career in the venture capital sector.

Michael Wong speaks to Wayne Yetter (founding CEO of AstraMerck) and Renold (Ren) Capocasale, CEO of FlowMetric Life Sciences, about making the transition from a Fortune 500 firm to a startup.

Dr. Johnny Khouri of CVS Health talks about how, even amid COVID-19, innovation can lead to role changes for individuals and continuous learning opportunities that employees can leverage.

Mariano García-Valiño and Renato De Giorgi, co-founders of Axenya, discuss the importance of timing in becoming a successful entrepreneur.

Harvard Business School's Dr. Lynda Applegate talks about how business leaders in the healthcare space are identifying opportunities not just to accelerate through the COVID-19 crisis, but to thrive in the future.

The Harvard Business School’s Dr. Laura Huang on how executives can manage their career concerns during and after the COVID-19 crisis.

Dr. Jeanne Ross of the MIT Center for Information Systems Research discusses how to lead an organization’s digital transformation for the pursuit of new revenue models.